ICCM
IceCure Medical Ltd NASDAQ Listed Aug 26, 2021$3.02
+0.67%
vs $3.00
Mkt Cap $6.8M
52w Low $2.12
2.3% of range
52w High $42.00
50d MA $3.93
200d MA $13.13
P/E (TTM)
—
EV/EBITDA
—
P/B
21.2x
Debt/Equity
0.0x
ROE
-166.4%
P/FCF
-13.1x
RSI (14)
53.80
ATR (14)
$0.31
Beta
2.52
50d MA
$3.93
200d MA
$13.13
Avg Volume
144.8K
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
7 Ha’Eshel Street · Caesarea 3079504 · IL
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | BMO | -1.52 | -3.11 | -104.6% | 3.51 | -14.5% | -11.5% | -3.5% | — | — | — | — |
| May 12, 2026 | BMO | -0.90 | -1.80 | -100.0% | 0.24 | -4.2% | +0.0% | -1.2% | +1.7% | -4.6% | -4.3% | — |
| Mar 17, 2026 | BMO | -1.20 | -1.80 | -50.0% | 0.67 | -3.0% | -9.8% | +4.8% | -0.1% | +1.4% | -4.5% | — |
| Nov 19, 2025 | BMO | -0.05 | -0.06 | -20.0% | 0.70 | -1.1% | -7.2% | +1.7% | +8.1% | -2.0% | +0.2% | — |
| Aug 13, 2025 | BMO | -0.06 | -0.06 | +0.0% | 0.84 | -3.6% | +0.2% | +6.7% | -0.7% | -3.6% | -0.6% | — |
| May 28, 2025 | BMO | -0.08 | -0.06 | +25.0% | 1.03 | +1.9% | +0.0% | +1.9% | +0.0% | -2.9% | +1.0% | — |
| Mar 27, 2025 | BMO | -0.07 | -0.08 | -8.7% | 1.11 | -1.8% | +0.0% | +6.3% | +5.1% | +0.0% | -0.8% | — |
| Nov 26, 2024 | BMO | -0.07 | -0.08 | -14.3% | 0.79 | -0.8% | +5.8% | +0.0% | -2.2% | -0.5% | +1.2% | — |
| Aug 20, 2024 | BMO | -0.07 | -0.06 | +14.3% | 0.75 | +0.7% | -1.0% | -7.0% | +3.3% | -3.8% | +0.0% | — |
| May 28, 2024 | BMO | -0.08 | -0.08 | +0.0% | 1.04 | +3.8% | -1.0% | +2.9% | +0.9% | -1.9% | -7.6% | — |
| Apr 3, 2024 | BMO | -0.07 | -0.07 | -1.9% | 1.25 | +4.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.8% | — |
| Nov 15, 2023 | BMO | -0.09 | -0.09 | +0.0% | 0.77 | -1.3% | -6.4% | +2.7% | +4.4% | -5.1% | +3.7% | — |
| Aug 14, 2023 | AMC | -0.09 | -0.08 | +11.1% | 0.96 | +0.0% | +5.2% | +0.0% | +2.0% | -1.9% | +1.0% | — |
| May 22, 2023 | AMC | -0.09 | -0.08 | +11.1% | 1.21 | -2.5% | -1.7% | -1.7% | -4.3% | -3.6% | +0.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.00 | $0.98 | -1.7% | -0.0% | -0.9% | -2.7% | -9.7% | -3.1% |
| Aug 15 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.84 | $0.86 | +2.1% | +6.7% | -0.7% | -3.6% | -0.6% | +2.4% |
| May 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.03 | $1.05 | +1.9% | +0.0% | +1.9% | +0.0% | -2.9% | +1.0% |
| Mar 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.11 | $1.09 | -1.8% | +0.0% | +6.3% | +5.1% | +0.0% | -0.8% |
| Nov 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.79 | $0.78 | -0.8% | +5.8% | +0.0% | -2.2% | -0.5% | +1.2% |
| Nov 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.74 | $0.72 | -2.7% | -11.7% | -6.8% | -3.1% | -6.8% | +7.3% |
| Sep 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.62 | $0.62 | +0.5% | +2.1% | -1.6% | -0.8% | +4.1% | +1.1% |
| Aug 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.75 | $0.76 | +0.7% | -1.0% | -7.0% | +3.3% | -3.8% | +0.0% |
| Jul 2 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.73 | $0.72 | -2.6% | +0.9% | -0.3% | -1.3% | +2.5% | -1.1% |
| Jun 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $0.97 | $0.95 | -1.9% | -15.5% | -9.8% | +2.4% | +0.3% | +1.3% |
| May 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.04 | $1.08 | +3.8% | -1.0% | +2.9% | +0.9% | -1.9% | -7.6% |
| Apr 16 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.35 | $1.35 | +0.0% | -3.7% | -0.8% | -4.7% | -1.6% | +0.8% |
| Apr 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.25 | $1.30 | +4.0% | +0.0% | +0.0% | +0.0% | +0.0% | -0.8% |
| Mar 20 | Alliance Global Partners | Maintains | Buy → Buy | — | $1.24 | $1.21 | -2.4% | -2.4% | +0.8% | -2.5% | +0.8% | -1.7% |
| Mar 20 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.24 | $1.21 | -2.4% | -2.4% | +0.8% | -2.5% | +0.8% | -1.7% |
| Mar 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $1.25 | $1.25 | +0.0% | +0.8% | -1.6% | +0.0% | +0.0% | +0.0% |
No insider trades available.
No recent filings available.
Institutional (13F) — Top 7
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Jane Street Group, Llc | 109,638 | $67K | New | Dec 2025 |
| 2 | Ubs Group Ag | 154,198 | $46K | Added | Mar 2026 |
| 3 | Hrt Financial Lp | 47,596 | $14K | Added | Mar 2026 |
| 4 | Morgan Stanley | 10,000 | $6K | Added | Dec 2025 |
| 5 | Lloyd Advisory Services, Llc. | 16,000 | $5K | New | Mar 2026 |
| 6 | Jpmorgan Chase & Co | 5,950 | $2K | — | Mar 2026 |
| 7 | Northwestern Mutual Wealth Management Co | 500 | $305 | New | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 0
All ↗
No N-PORT holders found.
Valuation
Market Cap
$6.8M
Enterprise Value
$183.1M
P/E (TTM)
—
Forward P/E
—
PEG Ratio
0.13x
P/B
21.21x
P/S
1.72x
P/FCF
-13.14x
EV/EBITDA
—
Shares Out
63.6M
Financials (TTM)
Revenue
$3.9M
Net Income
-$16.9M
EBITDA
-$16.4M
Free Cash Flow
-$14.6M
Op Cash Flow
-$14.6M
EPS Basic
$-0.24
EPS Diluted
$-6.76
EPS Forward
$-0.18
Gross Margin
36.1%
Op Margin
—
Net Margin
-427.7%
Balance Sheet
Total Assets
$13.9M
Total Liab.
$4.8M
Total Equity
$9.1M
Cash
$8.9M
LT Debt
$0
Book Value/Sh
$0.14
Debt/Equity
0.02x
Current Ratio
2.61
Quick Ratio
2.07
Returns & Growth
ROE
-166.4%
ROA
-108.4%
ROIC
-162.9%
Rev Growth YoY
+2.7%
EPS Growth YoY
+20.0%
Price Returns
2W
+4.5%
1M
-16.1%
3M
-56.2%
6M
-82.3%
12M
-88.8%
Technicals
52W High
$42.00
52W Low
$2.12
50d MA
$3.93
200d MA
$13.13
RSI (14)
53.80
ATR (14)
$0.31
Beta
2.52
Avg Volume
145K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$3.51
High
$5.75
Low
$2.00
Median
$2.77
Data updated apr 25, 2026 2:49pm
· Source: financialmodelingprep.com